Argent Trust Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.29M | Buy |
18,072
+2,278
| +14% | +$749K | 0.18% | 130 |
|
|
2025
Q4 | $5.54M | Buy |
15,794
+407
| +3% | +$138K | 0.19% | 118 |
|
|
2025
Q3 | $4.97M | Sell |
15,387
-3,093
| -17% | -$962K | 0.18% | 124 |
|
|
2025
Q2 | $7.19M | Buy |
18,480
+2,361
| +15% | +$950K | 0.27% | 80 |
|
|
2025
Q1 | $7.01M | Buy |
16,119
+4,345
| +37% | +$1.74M | 0.29% | 76 |
|
|
2024
Q4 | $4.34M | Buy |
11,774
+319
| +3% | +$133K | 0.18% | 114 |
|
|
2024
Q3 | $5.96M | Buy |
11,455
+811
| +8% | +$433K | 0.25% | 84 |
|
|
2024
Q2 | $5.77M | Buy |
10,644
+738
| +7% | +$390K | 0.25% | 84 |
|
|
2024
Q1 | $5.14M | Buy |
9,906
+752
| +8% | +$374K | 0.23% | 96 |
|
|
2023
Q4 | $4.32M | Buy |
9,154
+488
| +6% | +$226K | 0.21% | 104 |
|
|
2023
Q3 | $3.77M | Buy |
8,666
+1,377
| +19% | +$625K | 0.21% | 107 |
|
|
2023
Q2 | $3.24M | Buy |
7,289
+150
| +2% | +$69.2K | 0.18% | 123 |
|
|
2023
Q1 | $3.28M | Buy |
7,139
+263
| +4% | +$125K | 0.21% | 113 |
|
|
2022
Q4 | $3.53M | Sell |
6,876
-216
| -3% | -$110K | 0.23% | 96 |
|
|
2022
Q3 | $3.22M | Buy |
7,092
+606
| +9% | +$290K | 0.23% | 96 |
|
|
2022
Q2 | $3.13M | Sell |
6,486
-245
| -4% | -$121K | 0.21% | 104 |
|
|
2022
Q1 | $3.31M | Buy |
6,731
+1,440
| +27% | +$658K | 0.2% | 108 |
|
|
2021
Q4 | $2.45M | Sell |
5,291
-67
| -1% | -$28.2K | 0.14% | 140 |
|
|
2021
Q3 | $2M | Buy |
5,358
+222
| +4% | +$84.4K | 0.13% | 152 |
|
|
2021
Q2 | $1.96M | Buy |
5,136
+99
| +2% | +$37.8K | 0.13% | 149 |
|
|
2021
Q1 | $1.81M | Buy |
5,037
+122
| +2% | +$39.2K | 0.13% | 156 |
|
|
2020
Q4 | $1.58M | Sell |
4,915
-153
| -3% | -$47K | 0.12% | 157 |
|
|
2020
Q3 | $1.36M | Sell |
5,068
-20
| -0.4% | -$5.38K | 0.12% | 155 |
|
|
2020
Q2 | $1.34M | Buy |
5,088
+740
| +17% | +$197K | 0.13% | 154 |
|
|
2020
Q1 | $987K | Buy |
4,348
+93
| +2% | +$25.3K | 0.11% | 174 |
|
|
2019
Q4 | $1.29M | Buy |
4,255
+47
| +1% | +$12.9K | 0.11% | 170 |
|
|
2019
Q3 | $1.01M | Buy |
4,208
+387
| +10% | +$106K | 0.1% | 195 |
|
|
2019
Q2 | $1.08M | Buy |
3,821
+1,967
| +106% | +$537K | 0.11% | 178 |
|
|
2019
Q1 | $532K | Buy |
1,854
+215
| +13% | +$62.2K | 0.06% | 275 |
|
|
2018
Q4 | $430K | Sell |
1,639
-32
| -2% | -$8.8K | 0.05% | 288 |
|
|
2018
Q3 | $449K | Sell |
1,671
-35
| -2% | -$9.09K | 0.05% | 284 |
|
|
2018
Q2 | $405K | Buy |
1,706
+422
| +33% | +$97.7K | 0.05% | 303 |
|
|
2018
Q1 | $282K | Buy |
+1,284
| New | +$302K | 0.08% | 226 |
|
Other funds holding ELV
VCM
VPM
Argent Trust Co's ELV Position: Q1 2026 in Review
Argent Trust Co increased its Elevance Health (ELV) stake by 14% in Q1 2026, buying an estimated $749K and bringing the position to 18,072 shares worth $5.29M. The position accounts for 0.18% of the portfolio, ranked #130.
Argent Trust Co first reported a position in ELV in Q1 2018 and has held it in 33 quarters since. The position peaked at $7.19M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Argent Trust Co held 18,072 shares of Elevance Health worth $5.29M as of Q1 2026.
- Argent Trust Co bought 2,278 Elevance Health shares in Q1 2026, an estimated $749K.
- Elevance Health made up 0.18% of Argent Trust Co's portfolio in Q1 2026, its #130 holding.
- Argent Trust Co first reported a position in Elevance Health in Q1 2018 and has held it in 33 quarters since.
- Argent Trust Co's Elevance Health position peaked at $7.19M in Q2 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.